[1]
Chakrabarty, P. et al. 2024. Silymarin-choline combination versus ursodeoxycholic acid in non-alcoholic fatty liver disease: A randomized double-blind clinical trial.
Asian Journal of Medical Sciences
. 15, 4 (Apr. 2024), 70–77.